Pre-eclampsia Risk in Egg Recipients Study
Part of Blood & lymphatic, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your BMI should be under 35.
- You must have had a normal vaginal swab test in the last three years.
- You can have had children before or not, and you can be pregnant with one or more babies.
- You cannot have certain health issues like HIV, hepatitis, high blood pressure, kidney disease, heart disease, or cancer (past or present).
- You cannot smoke, abuse alcohol or drugs, or be breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the genetic match between the egg donor, the mother, and the baby affects the risk of high blood pressure during pregnancy (preeclampsia). It may help doctors understand why some pregnancies after egg donation have complications.
This trial studies ways to lower the risk of pre-eclampsia (dangerous high blood pressure in pregnancy) in women who are having a first pregnancy through IVF/ICSI or who have PCOS. It’s aimed at people considered higher risk for pre-eclampsia.
This trial follows women who have had preeclampsia to learn more about their health after pregnancy. It collects blood and tissue samples to find markers that could improve future care.
This study looks at how the lining of the womb (the luteal phase) affects the placenta in early pregnancy. It aims to understand why some pregnancies have complications and may help improve care for future pregnancies.
This study tests a new blood-filtering device (KNP-1000) to help manage severe preeclampsia, a serious high blood pressure condition during pregnancy. The goal is to see if it is safe and can help stabilize your blood pressure, possibly allowing you to stay pregnant longer.
This pilot study looks at tiny particles in blood (microvesicles) to learn how they differ in women with threatened preterm delivery, with or without pre-eclampsia. Results may help doctors better identify risk and improve care for early delivery.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.